ONC201, also known as TIC10 is a small molecule inhibitor of Dopamine Receptor D2 (DRD2) recently showing promise as a well‐tolerated anti‐cancer agent in limited Phase I and Phase II clinical studies.19 The gene discussed is DRD2; the disease is cancer.